Cureus
John H. Krystal
Create your FREE profile now!

Join the discussion with physicians and researchers around the globe - sign up for your free Cureus account today.

ADVERTISEMENT
About

John H. Krystal is the Robert L. McNeil Jr. Chairman of the Department of Psychiatry at Yale University School of Medicine. He is the Chief of Psychiatry at Yale-New Haven Hospital; Director, NIAAA Center for Translational Neuroscience and the Neuroscience of Alcoholism. Director, Clinical Neuroscience Division, VA National Center for PTSD; Director, VA Alcohol Research Center, and the Medical Director of the Schizophrenia Biological Research Center, Department of Veteran Affairs.

Dr. Krystal is a leading expert in the areas of alcoholism, schizophrenia, and post-traumatic stress disorders. His work links psychopharmacology, neuroimaging, and molecular genetics to study the neurobiology and to develop novel treatments for these disorders. Dr. Krystal has published over 400 papers and reviews and has presented his research extensively, across the globe.

Dr. Krystal graduated from the Yale University School of Medicine in 1984, where he subsequently continued his Residency training in Psychiatry. He is the recipient of a number of prestigious career awards such as the Kempf Award for Contributions to Schizophrenia Research through Research and Mentorship (American Psychiatric Association), the Anna-Monika Prize in Depression Research (Anna-Monika Foundation, Munich, Germany), the Stanley Dean Award for Schizophrenia Research (American College of Psychiatry), the Joel Elkes Award for translational neuroscience (American College of Neuropsychopharmacology), and the Jack Mendelson Award for Clinical Research (National Institute on Alcohol Abuse and Alcoholism). This year, Dr. Krystal was granted the Exemplary Psychiatrist Award by the National Alliance on Mental Illness.

Dr. Krystal currently serves as Editor of Biological Psychiatry; he is a member of the National Alcohol Abuse and Alcoholism Advisory Council (NIAAA), the Department of Defense Psychological Health Advisory Committee, and the Institute of Medicine of the U.S. National Academy of Sciences, and he is the President of the American College of Neuropsychopharmacology.

ADVERTISEMENT